Analystreport

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.

Bellicum Pharmaceuticals, Inc.  (BLCM) 
Last bellicum pharmaceuticals, inc. earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.bellicum.com/investor-overview